Full Text
Cost-Effectiveness of Targeted Therapeutics In Metastatic Renal Cell Cancer Seen From Two Different Economic Perspectives

Abstract

Authors

J Mihajlović M.J. Postma

Back to Volume 17, Issue 3
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×